{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T05:01:20Z","timestamp":1768453280566,"version":"3.49.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Cooperative Research Program for Agriculture Science and Technology Development","award":["PJ0099562014"],"award-info":[{"award-number":["PJ0099562014"]}]},{"name":"Rural Development Administration, Republic of Korea"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.jcyt.2014.04.005","type":"journal-article","created":{"date-parts":[[2014,6,13]],"date-time":"2014-06-13T14:30:21Z","timestamp":1402669821000},"page":"1441-1448","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Optimal condition of heparin-conjugated fibrin with bone morphogenetic protein-2 for spinal fusion in a rabbit model"],"prefix":"10.1016","volume":"16","author":[{"given":"Jae-Young","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun-Woong","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Wook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Woo","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You-Jin","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Ho","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2014.04.005_bib1","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/BRS.0b013e31821bfa3a","article-title":"Use of bone morphogenetic proteins in spinal fusion surgery for older adults with lumbar stenosis: trends, complications, repeat surgery, and charges","volume":"37","author":"Deyo","year":"2012","journal-title":"Spine"},{"key":"10.1016\/j.jcyt.2014.04.005_bib2","first-page":"125","article-title":"The safety and utility of recombinant human bone morphogenetic protein-2 for cranial procedures in a nonhuman primate model","volume":"98","author":"Sheehan","year":"2003","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.jcyt.2014.04.005_bib3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1517\/14740338.4.1.75","article-title":"Application of bone morphogenetic proteins in orthopaedic practice: their efficacy and side effects","volume":"4","author":"Harwood","year":"2005","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jcyt.2014.04.005_bib4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1525-1594.2012.01578.x","article-title":"Controlled delivery of low-dose bone morphogenetic protein-2 using heparin-conjugated fibrin in the posterolateral lumbar fusion of rabbits","volume":"37","author":"Koo","year":"2013","journal-title":"Artif Organs"},{"key":"10.1016\/j.jcyt.2014.04.005_bib5","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1525-1594.2012.01444.x","article-title":"Lumbar posterolateral fusion using heparin-conjugated fibrin for sustained delivery of bone morphogenic protein-2 in a rabbit model","volume":"36","author":"Koo","year":"2012","journal-title":"Artif Organs"},{"key":"10.1016\/j.jcyt.2014.04.005_bib6","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1525-1594.2011.01420.x","article-title":"The effect of the delivery carrier on the quality of bone formed via bone morphogenetic protein-2","volume":"36","author":"La","year":"2012","journal-title":"Artif Organs"},{"key":"10.1016\/j.jcyt.2014.04.005_bib7","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1089\/ten.tea.2009.0390","article-title":"Heparin-conjugated fibrin as an injectable system for sustained delivery of bone morphogenetic protein-2","volume":"16","author":"Yang","year":"2010","journal-title":"Tissue Eng Part A"},{"key":"10.1016\/j.jcyt.2014.04.005_bib8","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3858\/emm.2012.44.5.039","article-title":"Comparison between heparin-conjugated fibrin and collagen sponge as bone morphogenetic protein-2 carriers for bone regeneration","volume":"44","author":"Yang","year":"2012","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jcyt.2014.04.005_bib9","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1016\/j.biomaterials.2007.02.023","article-title":"Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(L-lactic-co-glycolic acid) scaffold","volume":"28","author":"Jeon","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.jcyt.2014.04.005_bib10","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00007632-199502001-00003","article-title":"An experimental lumbar intertransverse process spinal fusion model. Radiographic, histologic, and biomechanical healing characteristics","volume":"20","author":"Boden","year":"1995","journal-title":"Spine"},{"key":"10.1016\/j.jcyt.2014.04.005_bib11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00007632-200101150-00004","article-title":"2000 Young Investigator Research Award winner. Evaluation of OP-1 as a graft substitute for intertransverse process lumbar fusion","volume":"26","author":"Grauer","year":"2001","journal-title":"Spine"},{"key":"10.1016\/j.jcyt.2014.04.005_bib12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/BRS.0b013e318162451b","article-title":"Posterolateral intertransverse spinal fusion possible in osteoporotic rats with BMP-7 in a higher dose delivered on a composite carrier","volume":"33","author":"Lu","year":"2008","journal-title":"Spine"},{"key":"10.1016\/j.jcyt.2014.04.005_bib13","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1097\/01.brs.0000172230.01655.55","article-title":"Estrogen-dependent actions of bone morphogenetic protein-7 on spine fusion in rats","volume":"30","author":"Moazzaz","year":"2005","journal-title":"Spine"},{"key":"10.1016\/j.jcyt.2014.04.005_bib14","doi-asserted-by":"crossref","first-page":"E274","DOI":"10.1097\/BRS.0b013e3182055a6b","article-title":"Trends in the use of bone morphogenetic protein as a substitute to autologous iliac crest bone grafting for spinal fusion procedures in the United States","volume":"36","author":"Lad","year":"2011","journal-title":"Spine"},{"key":"10.1016\/j.jcyt.2014.04.005_bib15","doi-asserted-by":"crossref","first-page":"192e","DOI":"10.1097\/PRS.0b013e3181a66f52","article-title":"Bone morphogenetic proteins in cranial reconstructions: clinical evaluation of heparin-chitosan as a carrier for BMP-2","volume":"123","author":"Docherty","year":"2009","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jcyt.2014.04.005_bib16","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jconrel.2011.06.027","article-title":"Affinity-based growth factor delivery using biodegradable, photocrosslinked heparin-alginate hydrogels","volume":"154","author":"Jeon","year":"2011","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.jcyt.2014.04.005_bib17","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.bbrc.2008.02.099","article-title":"Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery","volume":"369","author":"Jeon","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jcyt.2014.04.005_bib18","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s11373-008-9277-4","article-title":"Enhancement of ectopic bone formation by bone morphogenetic protein-2 delivery using heparin-conjugated PLGA nanoparticles with transplantation of bone marrow-derived mesenchymal stem cells","volume":"15","author":"Kim","year":"2008","journal-title":"J\u00a0Biomed Sci"},{"key":"10.1016\/j.jcyt.2014.04.005_bib19","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3109\/17453674.2011.636675","article-title":"Improved spinal fusion efficacy by long-term delivery of bone morphogenetic protein-2 in a rabbit model","volume":"82","author":"Lee","year":"2011","journal-title":"Acta Orthop"},{"key":"10.1016\/j.jcyt.2014.04.005_bib20","doi-asserted-by":"crossref","first-page":"23246","DOI":"10.1074\/jbc.M511039200","article-title":"Heparin potentiates the in vivo ectopic bone formation induced by bone morphogenetic protein-2","volume":"281","author":"Zhao","year":"2006","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jcyt.2014.04.005_bib21","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/j.biomaterials.2005.10.007","article-title":"Optimized use of a biodegradable polymer as a carrier material for the local delivery of recombinant human bone morphogenetic protein-2 (rhBMP-2)","volume":"27","author":"Kato","year":"2006","journal-title":"Biomaterials"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324914005623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324914005623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:20:30Z","timestamp":1761430830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324914005623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S1465324914005623"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2014.04.005","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimal condition of heparin-conjugated fibrin with bone morphogenetic protein-2 for spinal fusion in a rabbit model","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2014.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}